Trials / Completed
CompletedNCT04298268
The CUSA Clarity Soft Tissue Removal Study
Clinical Performance Investigation of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Soft Tissue Removal During Urological and General Surgery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Integra LifeSciences Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the clinical performance and surgeon preferences of the CUSA® Clarity Ultrasonic Surgical Aspirator System for soft tissue removal during surgical procedures. This will be evaluated through the effectiveness of soft tissue removal per surgeon assessment and Incidence of Adverse Device Effects.
Conditions
- Benign, Malignant Tumors or Other Soft Tissue Removal
- Nephrectomy or Partial Nephrectomy With Parenchyma Removal
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CUSA Clarity Ultrasonic Surgical Aspirator System use | Assessment of the CUSA® Clarity Ultrasonic Surgical Aspirator System use during urological or general surgery for soft tissue removal |
Timeline
- Start date
- 2020-03-30
- Primary completion
- 2021-11-24
- Completion
- 2021-11-24
- First posted
- 2020-03-06
- Last updated
- 2022-02-08
Locations
5 sites across 2 countries: Germany, Italy
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04298268. Inclusion in this directory is not an endorsement.